These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 27008039)

  • 1. Use of Menopausal Hormone Therapy and Bioidentical Hormone Therapy in Australian Women 50 to 69 Years of Age: Results from a National, Cross-Sectional Study.
    Velentzis LS; Banks E; Sitas F; Salagame U; Tan EH; Canfell K
    PLoS One; 2016; 11(3):e0146494. PubMed ID: 27008039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence.
    Collaborative Group on Hormonal Factors in Breast Cancer
    Lancet; 2019 Sep; 394(10204):1159-1168. PubMed ID: 31474332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menopausal hormone therapy: Characterising users in an Australian national cross-sectional study.
    Velentzis LS; Egger S; Banks E; Canfell K
    PLoS One; 2021; 16(8):e0253725. PubMed ID: 34379634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is breast cancer risk the same for all progestogens?
    Stute P
    Arch Gynecol Obstet; 2014 Aug; 290(2):207-9. PubMed ID: 24838289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of hormone therapy among women with hysterectomy/oophorectomy.
    Chen L; Mishra GD; Dobson AJ; Wilson LF; Jones MA
    Hum Reprod; 2017 Apr; 32(4):885-892. PubMed ID: 28184451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menopause, hysterectomy, menopausal hormone therapy and cause-specific mortality: cohort study of UK Biobank participants.
    Xu Z; Chung HF; Dobson AJ; Wilson LF; Hickey M; Mishra GD
    Hum Reprod; 2022 Aug; 37(9):2175-2185. PubMed ID: 35690930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and impact of vaginal symptoms among postmenopausal women.
    Santoro N; Komi J
    J Sex Med; 2009 Aug; 6(8):2133-42. PubMed ID: 19493278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Menopausal hormone therapy use and breast cancer risk in Australia: Findings from the New South Wales Cancer, Lifestyle and Evaluation of Risk study.
    Salagame U; Banks E; Sitas F; Canfell K
    Int J Cancer; 2016 Apr; 138(8):1905-14. PubMed ID: 26599391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of reproductive history and exogenous hormone use on prevalence and frequency of circulating t(14;18)-positive cells in a population-based cross-sectional study.
    Weitmann K; Hirt C; Schwarz S; Rabkin C; Dölken G; Hoffmann W
    Cancer Causes Control; 2015 Mar; 26(3):455-65. PubMed ID: 25634026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knowledge and attitudes of health professionals regarding menopausal hormone therapies.
    Yeganeh L; Boyle J; Teede H; Vincent A
    Climacteric; 2017 Aug; 20(4):348-355. PubMed ID: 28379046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in menopausal hormone therapy use among women in Germany between 1998 and 2003.
    Du Y; Dören M; Melchert HU; Scheidt-Nave C; Knopf H
    BMC Womens Health; 2007 Oct; 7():19. PubMed ID: 17945013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Menopausal hormone therapy, oral contraceptives and risk of chronic low back pain: the HUNT Study.
    Heuch I; Heuch I; Hagen K; Storheim K; Zwart JA
    BMC Musculoskelet Disord; 2023 Jan; 24(1):84. PubMed ID: 36721124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Menopausal hormone therapy may increase non-allergic rhinitis among postmenopausal women: Results from the Korea National Health and Nutrition Examination Survey (2010-2012).
    Choi JH; Hwang SH; Suh JD; Kim JK; Hong SC; Lim YC; Kim SN; Cho JH
    Maturitas; 2017 Aug; 102():46-49. PubMed ID: 28610682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent gap in menopause care 20 years after the WHI: a population-based study of menopause-related symptoms and their management.
    Trémollieres FA; André G; Letombe B; Barthélemy L; Pichard A; Gelas B; Lopès P
    Maturitas; 2022 Dec; 166():58-64. PubMed ID: 36058119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of offering menopause hormone therapy among primary care doctors and its associated factors: A cross-sectional study.
    Low TL; Cheong AT; Devaraj NK; Ismail R
    PLoS One; 2024; 19(9):e0310994. PubMed ID: 39321159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hysterectomy and incidence of depressive symptoms in midlife women: the Australian Longitudinal Study on Women's Health.
    Wilson L; Pandeya N; Byles J; Mishra G
    Epidemiol Psychiatr Sci; 2018 Aug; 27(4):381-392. PubMed ID: 28190411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between menopausal hormone therapy and the risk of gastric cancer: A Korean nationwide population-based cohort study.
    Han KH; Choi YJ; Han K; Shin CM; Park NH; Lee DH
    Maturitas; 2024 Jun; 184():107960. PubMed ID: 38460415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of menopausal hormone therapy use in Korea (2002-2013): A nationwide cohort study.
    Park CY; Lim JY; Kim WH; Kim SY; Park HY
    Maturitas; 2021 Apr; 146():57-62. PubMed ID: 33722365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menopausal hormone therapy and gallbladder disease: the Study of Health in Pomerania (SHIP).
    Schwarz S; Völzke H; Baumeister SE; Hampe J; Dören M
    Clin Endocrinol (Oxf); 2007 Jul; 67(1):51-9. PubMed ID: 17437513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menopausal Hormone Therapy Use Among Postmenopausal Women.
    Yang L; Toriola AT
    JAMA Health Forum; 2024 Sep; 5(9):e243128. PubMed ID: 39331372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.